REAP Financial Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$263K Buy
3,722
+441
+13% +$33K 0.05% 106
2025
Q4
$259K Buy
3,281
+351
+12% +$27.8K 0.05% 108
2025
Q3
$241K Buy
2,930
+368
+14% +$29K 0.05% 106
2025
Q2
$206K Buy
2,562
+1,182
+86% +$91.2K 0.05% 114
2025
Q1
$111K Buy
1,380
+443
+47% +$36.8K 0.03% 144
2024
Q4
$76.7K Buy
937
+235
+33% +$19.6K 0.02% 177
2024
Q3
$57.9K Sell
702
-4
-0.6% -$299 0.01% 192
2024
Q2
$49.6K Sell
706
-34
-5% -$2.43K 0.01% 192
2024
Q1
$54.8K Sell
740
-2,227
-75% -$155K 0.02% 195
2023
Q4
$196K Buy
+2,967
New +$186K 0.06% 134

Other funds holding MET

REAP Financial Group's MET Position: Q1 2026 in Review

REAP Financial Group increased its MetLife (MET) stake by 13% in Q1 2026, buying an estimated $33K and bringing the position to 3,722 shares worth $263K. The position accounts for 0.05% of the portfolio, ranked #106.

REAP Financial Group first reported a position in MET in Q4 2023 and has held it in 10 quarters since. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • REAP Financial Group held 3,722 shares of MetLife worth $263K as of Q1 2026.
  • REAP Financial Group bought 441 MetLife shares in Q1 2026, an estimated $33K.
  • MetLife made up 0.05% of REAP Financial Group's portfolio in Q1 2026, its #106 holding.
  • REAP Financial Group first reported a position in MetLife in Q4 2023 and has held it in 10 quarters since.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on REAP Financial Group's 13F filing for Q1 2026, filed 11 May 2026.